Literature DB >> 25286927

Angiopoietin-2, its soluble receptor Tie-2 and subclinical cardiovascular disease in a population-based sample.

Roberto Lorbeer1, Sebastian E Baumeister1, Marcus Dörr2, Stephan B Felix2, Matthias Nauck3, Anne Grotevendt4, Marcello R P Markus1, Bettina von Sarnowski5, Henry Völzke6, Ramachandran S Vasan7, Henri Wallaschofski3, Wolfgang Lieb8.   

Abstract

OBJECTIVE: Higher circulating Angiopoietin-2 (Ang-2) levels predict cardiovascular events and mortality in clinical samples and in the general population. To better understand the underlying mechanisms, we investigated the association of circulating Ang-2 and sTie-2 (the soluble form of the Ang-2 receptor) levels with various measures of subclinical cardiovascular disease.
METHODS: Cross-sectional data of 3204 participants (1654 women) aged 25-88 years from the population-based Study of Health in Pomerania were analysed. LV mass (LVM) and fractional shortening were determined echocardiographically as indices of cardiac structure and function, respectively. Intima media thickness (IMT) of the common carotid artery, the number of carotid plaques and flow-mediated dilation (FMD) were used to characterise large and medium-sized arterial structure and function.
RESULTS: Multivariable-adjusted linear and negative binomial regression models revealed an inverse association of circulating Ang-2 levels (independent variable) with fractional shortening (ß=-0.51 per 1 SD increment; 95% CI -0.86 to -0.16, p=0.005) and a positive association with number of carotid plaques (rate ratio=1.04 95% CI 1.01 to 1.07, p=0.019). No associations of Ang-2 or sTie-2 with LVM, IMT and FMD were found.
CONCLUSIONS: Circulating Ang-2 levels were associated with select subclinical cardiovascular disease traits, consistent with the notion that the Ang-2-pathway plays a role in mediating cardiovascular morbidity. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25286927     DOI: 10.1136/heartjnl-2014-306056

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  9 in total

1.  Angiogenic factors as prognostic markers in neuroendocrine neoplasms.

Authors:  Giulia Puliani; Franz Sesti; Emanuela Anastasi; Monica Verrico; Maria Grazia Tarsitano; Tiziana Feola; Federica Campolo; Cira Rosaria Tiziana Di Gioia; Mary Anna Venneri; Antonio Angeloni; Marialuisa Appetecchia; Andrea Lenzi; Andrea Marcello Isidori; Antongiulio Faggiano; Elisa Giannetta
Journal:  Endocrine       Date:  2022-01-28       Impact factor: 3.925

2.  Circulating growth factors and cardiac remodeling in the community: The Framingham Heart Study.

Authors:  Cecilia Castro-Diehl; Rebecca J Song; Douglas B Sawyer; Kai C Wollert; Gary F Mitchell; Susan Cheng; Ramachandran S Vasan; Vanessa Xanthakis
Journal:  Int J Cardiol       Date:  2021-01-07       Impact factor: 4.164

3.  Associations of Angiopoietins With Heart Failure Incidence and Severity.

Authors:  Brandon S Peplinski; Brian A Houston; David A Bluemke; Steven M Kawut; Todd M Kolb; Richard A Kronmal; Joao A C Lima; David D Ralph; Samuel G Rayner; Zachary L Steinberg; Ryan J Tedford; Peter J Leary
Journal:  J Card Fail       Date:  2021-04-17       Impact factor: 6.592

4.  Angiopoietin-2 as a Prognostic Biomarker of Major Adverse Cardiovascular Events and All-Cause Mortality in Chronic Kidney Disease.

Authors:  Yi-Chun Tsai; Chee-Siong Lee; Yi-Wen Chiu; Hung-Tien Kuo; Su-Chu Lee; Shang-Jyh Hwang; Mei-Chuan Kuo; Hung-Chun Chen
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

5.  Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease.

Authors:  Yi-Chun Tsai; Chee-Siong Lee; Yi-Wen Chiu; Hung-Tien Kuo; Su-Chu Lee; Shang-Jyh Hwang; Mei-Chuan Kuo; Hung-Chun Chen
Journal:  Sci Rep       Date:  2016-12-19       Impact factor: 4.379

6.  Systemic angiopoietin-1/2 dysregulation following cardiopulmonary bypass in adults.

Authors:  Emmanuel Charbonney; Elizabeth Wilcox; Yuexin Shan; Pablo Perez d'Empaire; Abhijit Duggal; Gordon D Rubenfeld; Conrad Liles; Claudia Dos Santos
Journal:  Future Sci OA       Date:  2017-01-11

7.  Increased levels of angiogenic factors in microvascular angina.

Authors:  Elmira Roshani Asl; Yousef Rasmi; Mohammad-Hasan Khadem-Ansari; MirHossein Seyed-Mohammadzad; Alireza Rostamzadeh; Fereshteh Ghaffari; Narmin Mokarizadeh
Journal:  Med Pharm Rep       Date:  2019-01-15

8.  Association between angiopoietin-2 and functional cardiac remodeling in hemodialysis patients with normal left ventricular ejection.

Authors:  Ana Aécia Alexandrino de Oliveira; Thaís Alexandrino de Oliveira; Larissa Alexandrino de Oliveira; Gdayllon Cavalcante Meneses; Gabriela Freire Bezerra; Alice Maria Costa Martins; Alexandre Braga Libório
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-03-16       Impact factor: 3.738

9.  Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI.

Authors:  Wen Jian; Lang Li; Xiao-Min Wei; Cheng-Qiang Wu; Chun Gui
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.